Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464776
Status:
COMPLETED
Last Update Posted:
2011-02-04
First Post:
2007-04-21
Brief Title:
Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy
Sponsor:
Organization:
Novartis